Search Results

Filter
  • 1-10 of  20,984 results for ""INTERFERON alpha""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.

  • Authors : Irani YD; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.; The University of Adelaide, School of Medicine, Adelaide, South Australia, Australia.

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy; Humans

  • Source: British journal of haematology [Br J Haematol] 2023 Sep; Vol. 202 (6), pp. 1127-1136. Date of Electronic Publication: 2023 Jul 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/adverse effects ; Leukemia, Myeloid, Chronic-Phase*/Leukemia, Myeloid, Chronic-Phase*/Leukemia, Myeloid, Chronic-Phase*/drug therapy; Humans

  • Source: British journal of haematology [Br J Haematol] 2023 Jan; Vol. 200 (2), pp. 175-186. Date of Electronic Publication: 2022 Oct 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer?

  • Authors : Riveiro-Barciela M; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Interferon-alpha*; Hepatitis, Chronic

  • Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Sep; Vol. 56 (5), pp. 912-913.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial.

  • Authors : Huang YW; PharmaEssentia Corporation, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/adverse effects; Humans

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 May; Vol. 88 (5), pp. 2396-2407. Date of Electronic Publication: 2021 Dec 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome.

  • Authors : Choi C; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; Moller D

Subjects: Hypereosinophilic Syndrome/Hypereosinophilic Syndrome/Hypereosinophilic Syndrome/*drug therapy ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*administration & dosage ; Polyethylene Glycols/Polyethylene Glycols/Polyethylene Glycols/*administration & dosage

  • Source: British journal of haematology [Br J Haematol] 2020 Mar; Vol. 188 (5), pp. e68-e72. Date of Electronic Publication: 2019 Nov 13.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

The use of pegylated interferon a-2a in a cohort of Greek patients with mycosis fungoides.

  • Authors : Patsatsi A; 2nd Department of Dermatology and Venereology, School of Medicine, Aristotle University of Thessaloniki, 'Papageorgiou' General Hospital, Thessaloniki, Greece.; Papadavid E

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use ; Mycosis Fungoides*/Mycosis Fungoides*/Mycosis Fungoides*/drug therapy ; Polyethylene Glycols*/Polyethylene Glycols*/Polyethylene Glycols*/therapeutic use

  • Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Apr; Vol. 36 (4), pp. e291-e293. Date of Electronic Publication: 2021 NovPublisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The current role of interferon in hairy cell leukaemia: clinical and molecular aspects.

  • Authors : Assanto GM; Haematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.; Riemma C

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use ; Leukemia, Hairy Cell/Leukemia, Hairy Cell/Leukemia, Hairy Cell/*drug therapy

  • Source: British journal of haematology [Br J Haematol] 2021 Jul; Vol. 194 (1), pp. 78-82. Date of Electronic Publication: 2021 May 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.

  • Authors : Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.; Barbui T

Subjects: Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/diagnosis ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/drug therapy ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/genetics

  • Source: American journal of hematology [Am J Hematol] 2020 Dec; Vol. 95 (12), pp. 1599-1613. Date of Electronic Publication: 2020 Oct 23.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients.

Subjects: Biomarkers, Pharmacological*/Biomarkers, Pharmacological*/Biomarkers, Pharmacological*/analysis ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/diagnosis ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy

  • Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Feb; Vol. 51 (4), pp. 469-478. Date of Electronic Publication: 2020 Jan 14.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.

  • Authors : Tsaur I; Department of Urology, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.; Hudak L

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Histone Deacetylase Inhibitors/Histone Deacetylase Inhibitors/Histone Deacetylase Inhibitors/*therapeutic use ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2015 Aug; Vol. 19 (8), pp. 1795-804. Date of Electronic Publication: 2015 Mar 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  20,984 results for ""INTERFERON alpha""